Dale Rogers, executive chairman of Phoenix Gold, says margins among Australia's gold miners remain robust due to decreasing costs on the back of a weaker Australian dollar.» Read More
Anthem has agreed to acquire Cigna for $54.2 billion in a cash and stock deal, reports "Squawk Box's" Andrew Ross Sorkin.
Seijiro Takeshita, professor of management and information at University of Shizuoka, says the Japanese media group is hoping to beef up its "regional weakness" with the purchase of the FT Group.
UPS is in talks to acquire Chicago-based Coyote Logistics for $1.8 billion according to a source familiar with the matter.
CNBC's David Faber reports on the major legal roadblock in Teva's bid to acquire Mylan.
Pearson is in advanced talks to sell the FT Group to Germany's biggest newspaper company Axel Springer, the Financial Times reported.
Nikkei, the Japanese media company, has trumped Germany’s Axel Springer, in a tussle to buy the FT Group from Pearson for £844m, the FT reports.
Home Depot said it agreed to buy home repair and maintenance product seller Interline Brands for $1.63 billion.
Heart device maker St. Jude Medical said it would buy smaller rival Thoratec for $3.4 billion.
CNBC's Courtney Reagan reports that Dow Jones is reporting the Federal Communications Commission will approve AT&T's bid for DirectTV.
Joe Jimenez, CEO of Novartis, says the company is looking for bolt-on acquisitions worth between $1 bilion to $3 billion, rather than mega-mergers.
Timothy Walbert, Horizon Pharma chairman & CEO, talks about the company's earning providing patients access to drugs, and its bid for Depomed.
Miramax is exploring strategic alternatives including a potential sale, according to people familiar with the matter.
Italy is set to float its national post office in the first week of August, kicking off a 12 billion euro privatization program. The Financial Times reports.
CNBC's Mary Thompson looks ahead to what are likely to be next week's top business and financial stories.
As many firms look to snap up businesses in the hot merger and acquisitions market, one entrepreneur has founded a corporate matchmaking start-up.
Hugh Grant, Monsanto CEO, weighs in on GMO foods and pesticide use among growers.
Hugh Grant, Monsanto CEO, discusses his company's bid for Swiss pesticide maker Syngenta.
Noam Gottesman, Nomad Foods co-chairman, discusses his multibillion-dollar bet on frozen foods and ready-meals. Frozen food is much less wasteful than fresh food, says Gottesman.
Martin Franklin, Jarden executive chairman, provides insight on its bid to buy Waddington and create excitement around its products.
Opportunity Network is a digital platform to set up business deals. CEO Brian Pallas discusses.